Vaccine News – Dr. Suzanne Humphries, M.D. – Vaccine Strain of Measles Virus Found in Measles

Dirty Vaccines: Every Human Vaccine Tested Was Contaminated With Metals and Debris in New Study
Researchers examining 44 samples of 30 different vaccines found dangerous contaminants, including red blood cells in one vaccine and metal toxicants in every single sample tested – except in one animal vaccine.
Using extremely sensitive new technologies not used in vaccine manufacturing, Italian scientists reported they were “baffled” by their discoveries which included single particles and aggregates of organic debris including red cells of human or possibly animal origin and metals including lead, tungsten, gold, and chromium, that have been linked to autoimmune disease and leukemia.
In the study, published this week in the International Journal of Vaccines and Vaccination, the researchers led by Antoinetta Gatti, of the National Council of Research of Italy and the Scientific Director of Nanodiagnostics, say their results “show the presence of micro- and nano-sized particulate matter composed of inorganic elements in vaccine samples” not declared in the products’ ingredients lists.
Lead particles were found in the cervical cancer vaccines, Gardasil and Cevarix, for example, and in the seasonal flu vaccine Aggripal manufactured by Novartis as well as in the Meningetec vaccine meant to protect against meningitis C.
Samples of an infant vaccine called Infarix Hexa (against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B) manufactured by GlaxoSmithKline was found to contain stainless steel, tungsten and a gold-zinc aggregate.
Other metal contaminants included platinum, silver, bismuth, iron, and chromium. Chromium (alone or in alloy with iron and nickel) was identified in 25 of the human vaccines from Italy and France that were tested.
GSK’s Fluarix vaccine for children three years and older contained 11 metals and aggregates of metals. Similar aggregates to those identified in the vaccines have been shown to be prevalent in cases of leukemia, the researchers noted.
Many of the vaccines contained iron and iron alloys which, according to the researchers, “can corrode and the corrosion products exert a toxicity affecting the tissues”.
The researchers supply an image of an area in a drop of Sanofi Pasteur MSD’s Repevax (diphtheria, pertussis, tetanus, polio) vaccine “where the morphology of red cells – we cannot tell whether they are human or animal- is clearly visible” along with the presence of “debris” composed of aluminum, bromine, silicon, potassium and titanium.
Feligen, the only veterinary vaccine tested in the 44 total vaccines sampled, proved to be the only sample free from inorganic contamination.

Dirty Vaccines: New Study Reveals Prevalence of Contaminants
Posted by Celeste McGovern on Jan 30, 2017 5:31:20 PM
Every Human Vaccine Tested Was Contaminated by Unsafe Levels of Metals and Debris Linked to Cancer and Autoimmune Disease, New Study Reports
Researchers examining 44 samples of 30 different vaccines found dangerous contaminants, including red blood cells in one vaccine and metal toxicants in every single sample tested – except in one animal vaccine.
Using extremely sensitive new technologies not used in vaccine manufacturing, Italian scientists reported they were “baffled” by their discoveries which included single particles and aggregates of organic debris including red cells of human or possibly animal origin and metals including lead, tungsten, gold, and chromium, that have been linked to autoimmune disease and leukemia.
In the study, published this week in the International Journal of Vaccines and Vaccination, the researchers led by Antonietta Gatti, of the National Council of Research of Italy and the Scientific Director of Nanodiagnostics, say their results “show the presence of micro- and nano-sized particulate matter composed of inorganic elements in vaccine samples” not declared in the products’ ingredients lists.
Lead particles were found in the cervical cancer vaccines, Gardasil and Cervarix, for example, and in the seasonal flu vaccine Aggripal manufactured by Novartis as well as in the Meningetec vaccine meant to protect against meningitis C.
Samples of an infant vaccine called Infarix Hexa (against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B) manufactured by GlaxoSmithKline was found to contain stainless steel, tungsten and a gold-zinc aggregate.

PDF source: http://medcraveonline.com/IJVV/IJVV-04-00072.pdf
Study – New Quality-Control Investigations on Vaccines: Micro-and Nanocontamination
International Journal of Vaccines and Vaccination
Abstract
Vaccines  are  being  under  investigation  for  the  possible  side  effects  they  can cause. In order to supply new information, an electron-microscopy investigation method was applied to the study of vaccines, aimed at verifying the presence of solid contaminants by means of an Environmental Scanning Electron Microscope equipped  with  an  X-ray  microprobe.  The  results  of  this  new  investigation  show the presence of micro- and nanosized particulate matter composed of inorganic elements in vaccines’ samples which is not declared among the components and whose unduly presence is, for the time being, inexplicable. A considerable part of  those  particulate  contaminants  have  already  been  verified  in  other  matrices and  reported  in  literature  as  non  biodegradable  and  non  biocompatible.  The evidence  collected  is  suggestive  of  some  hypotheses  correlated  to  diseases  that are mentioned and briefly discussed.

Parents of children with autistic spectrum disorder report extreme fatigue
Pamela Cowan, Regina Leader-Post
Published on: January 13, 2017
For more than two years, Sarah Elizabeth Ivens was fascinated to work one-on-one with children who have autism spectrum disorder.
“It’s amazing how the mind can work differently,” she said.
As she got to know the childrens’ families, Ivens was struck by the many challenges they juggled and their high level of fatigue.
“Fatigue is a sense of exhaustion that cannot be resolved by getting rest,” she said. “It’s not just being tired. If you’re tired, then you can go to bed early, sleep in and the next day you’re feeling better. That’s not the case with fatigue.”
Fatigue impacts a person’s physical and mental capacities.
Ivens completed her honours degree in psychology at the University of Victoria, and is now a PhD student in clinical psychology at the University of Regina.
Her Victoria experience spurred her to take a closer look at parents’ experiences for her master’s thesis, titled Fatigue in parents of children with Autism Spectrum Disorders: The role of parental and child factors for mothers and fathers.
“We do know from other research that fatigue is problematic for parents in general and that it can really have a big impact on their well-being and their child rearing, which results in less-effective parenting,” Ivens said.
Past research focused on mothers. For her thesis, Ivens surveyed 112 parents of children with autism between the ages of two and 12 years, with the average age being seven.
“The kids had been diagnosed three years prior, so this was not families going through the transition of learning to deal with the diagnosis,” Ivens said. “These were parents who were doing it for a few years.”
Of those answering the online questionnaires for her 2015 study, 78 were mothers and 34 were fathers.
Getting dads involved was important. In many studies, only 10 per cent are fathers, she said.
“I think their answers and experiences are really getting lost in the noise,” Ivens said.
According to existing literature, mothers report being more fatigued than fathers, the 31-year-old said.
Her survey echoed that finding.

Merck Created Hit List to “Destroy,” “Neutralize” or “Discredit” Dissenting Doctors
By Jim Edwards May 6, 2009
Merck made a “hit list” of doctors who criticized Vioxx, according to testimony in a Vioxx class action case in Australia. The list, emailed between Merck employees, contained doctors’ names with the labels “neutralise,” “neutralised” or “discredit” next to them.
According to The Australian, Merck emails from 1999 showed company execs complaining about doctors who disliked using Vioxx. One email said:
We may need to seek them out and destroy them where they live …
The plaintiffs’ lawyer gave this assessment:
It gives you the dark side of the use of key opinion leaders and thought leaders … if (they) say things you don’t like to hear, you have to neutralise them … It does suggest a certain culture within the organisation about how to deal with your opponents and those who disagree with you.
The Australian:
The court was told that James Fries, professor of medicine at Stanford University, wrote to the then Merck head Ray Gilmartin in October 2000 to complain about the treatment of some of his researchers who had criticised the drug.
“Even worse were allegations of Merck damage control by intimidation,” he wrote, … “This has happened to at least eight (clinical) investigators … I suppose I was mildly threatened myself but I never have spoken or written on these issues.”
The allegations come on the heels of revelations that Merck created a fake medical journal — the Australasian Journal of Bone and Joint Medicine — in which to publish studies about Vioxx; had pop songs commissioned about Vioxx to inspire its staff, and paid ghostwriters to draft articles about the drug.

New Merck Allegations: A Fake Journal; Ghostwritten Studies; Vioxx Pop Songs; PR Execs Harass Reporters
By Jim Edwards April 23, 2009
Federal prosecutors in the U.S. will be reading with amusement the Australian press’s coverage of a class action trial down under for patients who took Merck’s now-withdrawn painkiller Vioxx.
Details emerging in Oz make some of the antics that Merck’s American counterparts got up to look tame by comparison. For example, in Australia, Merck allegedly:
Had a doctor sign his name to an entirely ghostwritten journal article even though a Merck staffer had complained that the data within it was based on “wishful thinking.”
Created a fake “peer-reviewed” journal, the “Australasian Journal of Bone and Joint Medicine,” in which to publicize pro-Vioxx articles.
Created a Ricky Martin-style pop song to get Merck sales reps all jazzed up about Vioxx (lyrics below!).
During the trial, Merck has employed an unusually aggressive set of PR consultants, some of whom have even followed reporters into the bathroom to make sure they got the story “right.”
Hatched a Blackadder-style “cunning plan” to seed seminars with speakers who were sympathetic to Vioxx but under instructions not to mention the brand name too often.
Regarding the “wishful thinking” study, The Age reports on these emails turned over in the trial:
Email from Merck senior researcher Briggs Morrison, August 2001:
“That seems wishful thinking, not a critical interpretation of the data … The data appears to have been interpreted to support a preconceived hypothesis.”
The claim was nonetheless included in the final version of the article, which Merck employees sent to US cardiologist Dr Marv Konstam for approval.
Dr Konstam was named as the article’s lead author when it was published in the medical journal Circulation in October 2001
The Australian describes the fake journal. And The Age notes that the journal was “designed to resemble a peer-reviewed publication and reprinted previously published articles.”

Merck target of Vioxx federal grand jury probe
Mon Mar 23, 2009
Merck & Co said on Monday that it has been advised it is a target of a U.S. grand jury investigation involving its withdrawn pain drug Vioxx.
The company had previously disclosed the government probe, which has been ongoing since 2004. But it only last week received a letter from the U.S. Attorney’s office for the District of Massachusetts informing the drugmaker it is a target of the grand jury investigation, Merck said.
The probe involves Merck’s research, marketing and selling activities regarding Vioxx, the once $2.5 billion a year drug that was pulled from the market in September 2004 after a study showed it doubled the risk of heart attack and stroke in long-term users.
Merck said it has responded and will continue to respond to requests from the U.S. Attorney for documents and information in connection with the probe. The investigation includes subpoenas for witnesses to appear before a grand jury, the company has said in securities filings.
The New Jersey-based drugmaker was sued by tens of thousands of former Vioxx users who claimed to have been injured by the arthritis medicine.
After winning the majority of product liability trials that reached a jury, Merck agreed to pay $4.85 billion to settle personal injury claims from former users who had suffered heart attacks and strokes.

Study – Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to Humans
Principal Investigator: Arifa S. Khan, PhD
General Overview
The emergence of pathogenic virus infections like influenza and HIV have created an urgent need for new vaccines.
Virus-based vaccines are made in living cells (cell substrates). Some manufacturers are investigating the use of new cell lines to make vaccines. The continual growth of cell lines ensures that there is a consistent supply of the same cells that can yield high quantities of the vaccine.
In some cases the cell lines that are used might be tumorigenic, that is, they form tumors when injected into rodents. Some of these tumor-forming cell lines may contain cancer-causing viruses that are not actively reproducing. Such viruses are hard to detect using standard methods. These latent, or “quiet,” viruses pose a potential threat, since they might become active under vaccine manufacturing conditions. Therefore, to ensure the safety of vaccines, our laboratory is investigating ways to activate latent viruses in cell lines and to detect the activated viruses, as well as other unknown viruses, using new technologies. We will then adapt our findings to detect viruses in the same types of cell substrates that are used to produce vaccines. We are also trying to identify specific biological processes that reflect virus activity.
These methods will enable FDA scientists to help manufacturers to determine whether their specific cell substrate is safe to use for vaccine production. The methods our laboratory are developing and testing will help to ensure the production of safe and effective vaccines in two ways: 1) FDA will be able to develop testing guidelines for manufacturers who use new cell substrates for producing vaccines; and 2) FDA will publish the new methods it develops in peer-reviewed scientific journals, thus making them readily accessible to all manufacturers.
We are also evaluating the risk of retrovirus infections in humans. (Retroviruses are RNA viruses that use an enzyme called reverse transcriptase (RT) to replicate; RNA is the de-coded form of DNA). Simian foamy virus (SFV) can be transmitted from nonhuman primates (e.g., monkeys) to humans. Although there is no evidence that SFV causes disease, the virus can remain in a lifelong quiet state in the DNA after infection. Moreover, two individuals in Africa were recently found to be infected with both HIV-1 and SFV. Therefore, it is important to determine if SFV poses a threat to human health and to understand how the virus spreads in order to create strategies for controlling human infections. Such work will also help FDA to develop a new policy regarding blood donation by individuals working with nonhuman primates and implementing formal safety guidelines for people working with SFV-infected animals. We are also investigating the consequences of dual SFV and HIV-1 infection in the monkey model.

#RFKcommission – Great video! Dartmouth-educated and Portland, OR-based Pediatrician Dr. Paul Thomas responds to Dr. Peter Hotez’s ridiculous Op-Ed in the NY Times trying to talk President Trump out of having a Vaccine Safety Commission. Oregon proud!

Dr. Suzanne Humphries, M.D. – Vaccine Strain of Measles Virus Found in Measles Outbreaks
February 21, 2017
Health Impact News Editor Comments
Dr. Suzanne Humphries is a practicing nephrologist (kidney physician). In this lecture (video below), she addresses a study done in Croatia [1] where a child who was vaccinated with the MMR vaccine was tested positive for the measles vaccine strain Schwarz eight days after vaccination.
This was a significant finding, because the child’s symptoms were thought to be similar to rubella, and without testing, the sickness would have been possibly mis-diagnosed as rubella, or the wild-type strain of measles the vaccine is designed to protect against.
This concept of “shedding,” where the child comes down with the disease from the virus in the vaccine itself, surprised the researchers:
Virus excretion in vaccinees has been reported before, but to our knowledge, this is documented for the first time for the Schwarz vaccine strain. [1]
Since 2010, this phenomena of vaccine shedding with measles in the MMR vaccine has been observed in at least two other studies:
Differentiating the wild from the attenuated during a measles outbreak. Paediatrcis and Child Health, 2012:
In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine. Clinically differentiating measles from a nonmeasles rash is challenging, but can be supported by a thorough medical history evaluation. Rashes are expected to occur after immunization; nucleic acid testing can be used when it is difficult to differentiate between wild and attenuated strains. [2]
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, Eurosurveillance, 2013:
We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster. [3]
Are health officials testing cases of measles in the current outbreak in the United States, to determine if the measles strain is the wild strain of the vaccine strain?
Not likely, and it is not likely that the mainstream media “TV doctors” will even discuss this as they falsely vilify parents who choose not to administer the MMR vaccine to their children as the cause of these outbreaks. Some of these cases are confirmed to be among those who have received the MMR vaccine, and for those who have not been vaccinated, is it possible they were infected from those recently vaccinated when the vaccine was still “shedding,” and that the vaccine-strain of measles was passed on from the vaccinated child to the unvaccinated child?

Advertisements

One thought on “Vaccine News – Dr. Suzanne Humphries, M.D. – Vaccine Strain of Measles Virus Found in Measles

  1. I couldn’t reefrain fdom commenting. Weell written! Hey there!
    I’ve bwen followiung yur blo forr some time noww and inally ggot
    thhe bravery tto goo ahead and give yoou a shkut ouut freom Dallas Texas!
    Juust wante too say kkeep upp thee excdellent job! I amm
    sute tyis poost hhas touiched alll thhe interneet people,
    itts really rally pleasant atticle onn building upp
    neew webpage. http://Www.cspan.net/

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s